JANSSEN PHARMS FDA Approval NDA 020272

NDA 020272

JANSSEN PHARMS

FDA Drug Application

Application #020272

Documents

Letter2004-06-16
Letter2002-11-19
Letter2003-12-11
Letter2003-11-25
Letter2007-08-22
Letter2008-08-19
Letter2010-09-07
Letter2009-08-06
Letter2010-09-07
Letter2010-12-06
Label2004-06-16
Label2003-12-11
Label2006-10-11
Label2006-10-11
Label2005-08-19
Label2007-08-23
Label2007-08-23
Label2010-08-30
Label2009-08-06
Label2010-08-30
Label2011-08-25
Label2010-12-04
Label2011-06-16
Label2012-08-03
Review2007-07-20
Review2009-09-16
Review2008-02-19
Review2011-12-14
Other2004-11-03
Letter2002-03-03
Letter2003-11-28
Letter2003-12-11
Letter2004-06-16
Letter2006-10-18
Letter2006-10-18
Letter2005-08-19
Letter2007-08-22
Letter2010-09-07
Letter2011-08-26
Letter2011-09-28
Letter2010-09-07
Letter2011-06-17
Letter2012-08-03
Letter2011-09-28
Letter2012-03-13
Letter2014-05-09
Letter2016-03-03
Label2003-12-11
Label2011-09-30
Label2010-08-30
Label2010-08-30
Label2011-09-30
Label2014-04-29
Label2016-03-03
Review2011-02-15
Review2007-07-20
Review1997-10-17
Review2009-01-12
Review2009-09-16
Review2013-06-03
Review2013-06-03
Review2011-12-14
Other Important Information from FDA2011-12-20
Label2017-02-24
Letter2017-03-02
Pediatric DD Summary Review1900-01-01
Pediatric CDTL Review1900-01-01
Pediatric Medical Review1900-01-01
Pediatric Medical Review1900-01-01
Pediatric Statistical Review1900-01-01
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01
Pediatric Written Request1900-01-01
Letter2018-07-30
Label2018-08-09
Label2019-01-28
Letter2019-02-13
Letter2020-02-06
Label2020-02-07
Letter2021-02-17
Label2021-02-18
Label2022-12-05
Letter2022-12-05

Application Sponsors

NDA 020272JANSSEN PHARMS

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004
Discontinued005
Prescription007
Prescription008

Application Products

001TABLET;ORAL1MG1RISPERDALRISPERIDONE
002TABLET;ORAL2MG1RISPERDALRISPERIDONE
003TABLET;ORAL3MG1RISPERDALRISPERIDONE
004TABLET;ORAL4MG1RISPERDALRISPERIDONE
005TABLET;ORAL5MG0RISPERDALRISPERIDONE
007TABLET;ORAL0.5MG1RISPERDALRISPERIDONE
008TABLET;ORAL0.25MG1RISPERDALRISPERIDONE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1993-12-29PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1994-12-22PRIORITY
LABELING; LabelingSUPPL3AP1995-04-12STANDARD
LABELING; LabelingSUPPL4AP1996-02-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1996-03-07PRIORITY
LABELING; LabelingSUPPL6AP1998-04-02STANDARD
EFFICACY; EfficacySUPPL7AP1997-10-17STANDARD
EFFICACY; EfficacySUPPL8AP2002-03-03STANDARD
LABELING; LabelingSUPPL9AP1999-07-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1998-05-13PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1998-10-26PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1999-01-27PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1999-05-10PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1999-10-27PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2001-07-20PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2001-10-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2001-09-28PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2002-07-09PRIORITY
LABELING; LabelingSUPPL24AP2002-11-19STANDARD
LABELING; LabelingSUPPL25AP2003-10-29STANDARD
EFFICACY; EfficacySUPPL26AP2003-12-04STANDARD
EFFICACY; EfficacySUPPL27AP2003-12-04STANDARD
LABELING; LabelingSUPPL33AP2003-09-10STANDARD
LABELING; LabelingSUPPL35AP2003-11-21STANDARD
EFFICACY; EfficacySUPPL36AP2006-10-06PRIORITY
EFFICACY; EfficacySUPPL41AP2006-10-06PRIORITY
LABELING; LabelingSUPPL42AP2005-08-17STANDARD
EFFICACY; EfficacySUPPL46AP2007-08-22PRIORITY
EFFICACY; EfficacySUPPL47AP2007-08-22PRIORITY
LABELING; LabelingSUPPL54AP2008-08-14STANDARD
LABELING; LabelingSUPPL55AP2010-08-30STANDARD
LABELING; LabelingSUPPL56AP2009-07-19901 REQUIRED
LABELING; LabelingSUPPL58AP2010-08-30UNKNOWN
LABELING; LabelingSUPPL59AP2011-08-24STANDARD
LABELING; LabelingSUPPL60AP2011-09-24PRIORITY
LABELING; LabelingSUPPL61AP2010-08-30UNKNOWN
LABELING; LabelingSUPPL62AP2010-08-30UNKNOWN
LABELING; LabelingSUPPL63AP2010-12-01901 REQUIRED
LABELING; LabelingSUPPL64AP2011-06-15STANDARD
EFFICACY; EfficacySUPPL65AP2012-08-02STANDARD
LABELING; LabelingSUPPL66AP2011-09-24STANDARD
LABELING; LabelingSUPPL67AP2012-03-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL71AP2013-02-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL72AP2013-06-13PRIORITY
LABELING; LabelingSUPPL73AP2014-04-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL76AP2016-02-09PRIORITY
LABELING; LabelingSUPPL77AP2016-03-01STANDARD
LABELING; LabelingSUPPL78AP2017-02-23901 REQUIRED
LABELING; LabelingSUPPL80AP2018-07-27STANDARD
LABELING; LabelingSUPPL82AP2019-01-25STANDARD
LABELING; LabelingSUPPL83AP2021-02-12STANDARD
LABELING; LabelingSUPPL85AP2020-02-05901 REQUIRED
LABELING; LabelingSUPPL87AP2022-12-02STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL5Null0
SUPPL10Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL23Null0
SUPPL41Null0
SUPPL46Null8
SUPPL47Null6
SUPPL55Null6
SUPPL58Null7
SUPPL59Null7
SUPPL60Null0
SUPPL61Null6
SUPPL62Null6
SUPPL63Null6
SUPPL64Null6
SUPPL65Null6
SUPPL66Null7
SUPPL67Null7
SUPPL71Null0
SUPPL72Null0
SUPPL73Null15
SUPPL76Null0
SUPPL77Null15
SUPPL78Null6
SUPPL80Null6
SUPPL82Null15
SUPPL83Null6
SUPPL85Null7
SUPPL87Null6

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB
007PrescriptionAB
008PrescriptionAB

CDER Filings

JANSSEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20272
            [companyName] => JANSSEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"RISPERDAL","activeIngredients":"RISPERIDONE","strength":"1MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"},{"drugName":"RISPERDAL","activeIngredients":"RISPERIDONE","strength":"2MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"RISPERDAL","activeIngredients":"RISPERIDONE","strength":"3MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"RISPERDAL","activeIngredients":"RISPERIDONE","strength":"4MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"RISPERDAL","activeIngredients":"RISPERIDONE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RISPERDAL","activeIngredients":"RISPERIDONE","strength":"0.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"RISPERDAL","activeIngredients":"RISPERIDONE","strength":"0.25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"02\/12\/2021","submission":"SUPPL-83","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/020272Orig1s083,020588Orig1s071,021444Orig1s057,021346Orig1s061lbl.pdf\"}]","notes":""},{"actionDate":"02\/05\/2020","submission":"SUPPL-85","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/020272s085,020588s072,021444s058lbl.pdf\"}]","notes":""},{"actionDate":"01\/25\/2019","submission":"SUPPL-82","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020272s082,020588s070,021444s056lbl.pdf\"}]","notes":""},{"actionDate":"07\/27\/2018","submission":"SUPPL-80","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020272s080,020588s068,021444s054lbl.pdf\"}]","notes":""},{"actionDate":"02\/23\/2017","submission":"SUPPL-78","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020272s078,020588s066,021444s052lbl.pdf\"}]","notes":""},{"actionDate":"03\/01\/2016","submission":"SUPPL-77","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/020272s077,020588s065,021346s055,021444s051lbl.pdf\"}]","notes":""},{"actionDate":"04\/28\/2014","submission":"SUPPL-73","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020272s073,020588s062,021444s048lbl.pdf\"}]","notes":""},{"actionDate":"08\/02\/2012","submission":"SUPPL-65","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/020272s065,020588s053,021444s041lbl.pdf\"}]","notes":""},{"actionDate":"09\/24\/2011","submission":"SUPPL-66","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020272s060s066,020588s048s054,021444s035s042lbl.pdf\"}]","notes":""},{"actionDate":"09\/24\/2011","submission":"SUPPL-60","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020272s060s066,020588s048s054,021444s035s042lbl.pdf\"}]","notes":""},{"actionDate":"08\/24\/2011","submission":"SUPPL-59","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020272s059,020588s047,021444s034lbl.pdf\"}]","notes":""},{"actionDate":"06\/15\/2011","submission":"SUPPL-64","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020272s064,020588s052,021444s040lbl.pdf\"}]","notes":""},{"actionDate":"12\/01\/2010","submission":"SUPPL-63","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/020272s063,020588s051,021346s040,021444s039lbl.pdf\"}]","notes":""},{"actionDate":"08\/30\/2010","submission":"SUPPL-62","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/020272S-055S-058S-061S-062lbl.pdf\"}]","notes":""},{"actionDate":"08\/30\/2010","submission":"SUPPL-61","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/020272S-055S-058S-061S-062lbl.pdf\"}]","notes":""},{"actionDate":"08\/30\/2010","submission":"SUPPL-58","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/020272S-055S-058S-061S-062lbl.pdf\"}]","notes":""},{"actionDate":"08\/30\/2010","submission":"SUPPL-55","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/020272S-055S-058S-061S-062lbl.pdf\"}]","notes":""},{"actionDate":"07\/19\/2009","submission":"SUPPL-56","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020272s056,020588s044,021346s033,021444s03lbl.pdf\"}]","notes":""},{"actionDate":"08\/22\/2007","submission":"SUPPL-47","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020272s46s47,20588s36s37,21444s20s21lbl.pdf\"}]","notes":""},{"actionDate":"08\/22\/2007","submission":"SUPPL-46","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020272s46s47,20588s36s37,21444s20s21lbl.pdf\"}]","notes":""},{"actionDate":"10\/06\/2006","submission":"SUPPL-41","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/021444s008s015,020588s024s028s029,020272s036s041lbl.pdf\"}]","notes":""},{"actionDate":"10\/06\/2006","submission":"SUPPL-36","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/021444s008s015,020588s024s028s029,020272s036s041lbl.pdf\"}]","notes":""},{"actionDate":"08\/17\/2005","submission":"SUPPL-42","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/020272s042,020588s030,021444s016,021346s010lbl.pdf\"}]","notes":""},{"actionDate":"12\/04\/2003","submission":"SUPPL-27","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/20272s-26,27,20588s-17,18,21444s-2,3_risperdal_lbl.pdf\"}]","notes":""},{"actionDate":"12\/04\/2003","submission":"SUPPL-26","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/20272s-26,27,20588s-17,18,21444s-2,3_risperdal_lbl.pdf\"}]","notes":""},{"actionDate":"07\/02\/1999","submission":"SUPPL-9","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/1999\\\/20588s05lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"RISPERDAL","submission":"RISPERIDONE","actionType":"1MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"RISPERDAL","submission":"RISPERIDONE","actionType":"2MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"RISPERDAL","submission":"RISPERIDONE","actionType":"3MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"RISPERDAL","submission":"RISPERIDONE","actionType":"4MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"RISPERDAL","submission":"RISPERIDONE","actionType":"5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"RISPERDAL","submission":"RISPERIDONE","actionType":"0.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"RISPERDAL","submission":"RISPERIDONE","actionType":"0.25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2021-02-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.